BCL11A enhancer–edited hematopoietic stem cells persist in rhesus monkeys without toxicity
Selami Demirci(National Heart Lung and Blood Institute), John F. Tisdale(National Institutes of Health), Anne H. Shen(Broad Institute), Jackson Gamer(National Institute of Diabetes and Digestive and Kidney Diseases), Scot A. Wolfe(University of Massachusetts Chan Medical School), Nathaniel S. Linde(National Institutes of Health), Shondra M. Pruett‐Miller(Southwestern Medical Center), Aylin Bonifacino(National Institutes of Health), Alexis Leonard(National Institutes of Health), Naoya Uchida(National Heart Lung and Blood Institute), Yuxuan Wu(East China Normal University), Juan J. Haro‐Mora(National Institutes of Health), Claire Drysdale(National Institute of Diabetes and Digestive and Kidney Diseases), Theresa Engels(National Institutes of Health), Cícera R. Lazzarotto(St. Jude Children's Research Hospital), Jing Zeng(Broad Institute), Kevin Luk(University of Massachusetts Chan Medical School), Mitchell J. Weiss(St. Jude Children's Research Hospital), Tina Nassehi(National Institute of Diabetes and Digestive and Kidney Diseases), Morgan Yapundich(National Institute of Diabetes and Digestive and Kidney Diseases), Daniel E. Bauer(Harvard University), Jasmine Bonanno(Dana-Farber Cancer Institute), Robert E. Donahue(National Institute of Diabetes and Digestive and Kidney Diseases), Danilo Pellin(Dana-Farber/Boston Children's Cancer and Blood Disorders Center), Allen E. Krouse(National Institutes of Health), Shengdar Q. Tsai(St. Jude Children's Research Hospital), Shaina N. Porter(Washington University in St. Louis)
Cited by 67
Related Papers
Efficient genome editing in zebrafish using a CRISPR-Cas system
|Nature Biotechnology|2013|3k
High-fidelity CRISPR–Cas9 nucleases with no detectable genome-wide off-target effects
|Nature|2016|2.7k
GUIDE-seq enables genome-wide profiling of off-target cleavage by CRISPR-Cas nucleases
|Nature Biotechnology|2014|2.3k
CRISPResso2 provides accurate and rapid genome editing sequence analysis
|Nature Biotechnology|2019|1.8k
Engineered CRISPR-Cas9 nucleases with altered PAM specificities
|Nature|2015|1.7k